進入內容區塊
:::回首頁 網站導覽 員工專區 ENGLISH Việt Nam Indonesia
::: 目前位置: 首頁 > 為民服務 > 醫師簡介 > 腎臟內科
張貼至「Facebook」【另開新視窗】  張貼至「Plurk」【另開新視窗】  張貼至「Twitter」【另開新視窗】  友善列印-另開新視窗 字級設定： 小 中 大

腎臟內科

洪國欽 醫師
  • 發布單位：新北市立聯合醫院
  • 發布日期：2025-08-19
  • 類別：腎臟內科
  • 內容：
    網路掛號   網路掛號
     
    洪國欽 醫師
    中文：洪國欽 醫師
    英文  Hung, Kuo-Chin M.D.

    學歷
    菲律賓法蒂瑪醫學院醫學系

    經歷
    桃園敏盛醫院腎臟內科主任
    康寧大學講師
    大仁科技大學講師
    醫院整合醫學專科醫師
    中華民國腎臟專科醫師
    中華民國內科專科醫師
    台北馬階醫院腎臟科研究醫師

    專長
    高血壓、糖尿病、泌尿道感染、急慢性腎疾病、水腫、蛋白尿、腎骨病變、多囊腎、副甲狀腺亢進、血液透析、腹膜透析、一般內科
    學術論文
    • 1. Hung KC, Chao CT. Considerations on the impact of apixaban on patient-reported outcomes in frail older adults. Eur J Intern Med. 2025 May;135:141-142. doi: 10.1016/j.ejim.2025.02.020. Epub 2025 Feb 18. PMID: 39971651.

    • 2.  Hung KC, Lee MY, Hung SY, Sun CY, Wu CC, Lin CJ. Efficacy of novel activated bamboo charcoal in reducing uremic toxins and enhancing kidney function in chronic kidney disease patients: a pilot randomized controlled trial. PeerJ. 2025 Mar 12;13:e19007. doi: 10.7717/peerj.19007. PMID: 40093417.

    • 3.  Hung KC, Chao CT. Frailty as a Potential Modifier in the Triad of Cardiovascular Disease, Physical Activity, and Sedentary Behaviour. Can J Cardiol. 2025 Mar 8:S0828-282X(25)00184-9. doi: 10.1016/j.cjca.2025.03.004. Epub ahead of print. PMID: 40058729.

    • 4.  Hung KC, Chao CT. The Potential Outcome-Modification Influences Introduced by ESKD Life Plan on eGFR Slopes. J Am Soc Nephrol. 2025 Jan 1;36(1):159-160. doi: 10.1681/ASN.0000000522. Epub 2024 Oct 16. PMID: 39412888.

    • 5. Hung KC, Chao CT. Re: Jennifer Kranz, Riccardo Bartoletti, Franck Bruyère, et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur Urol. 2024;86:27-41. Eur Urol. 2024 Nov;86(5):e114-e115. doi: 10.1016/j.eururo.2024.05.032. Epub 2024 Jul 9.
    • 6. Hung KC, Chao CT. Frailty May Mediate the Relationship Between Depressive Symptoms, Antidepressant Use, and Mortality in Patients With Chronic Kidney Disease. Kidney Med. 2024 Aug 6;6(9):100886. doi: 10.1016/j.xkme.2024.100886. PMID: 39263212.
    • 7.  Lin YT, Zheng CM, Hung KC, Yang HC, Zheng ML, Huang CW. Evaluating the Effectiveness of a Novel Personalized Health Education Approach for Hemodialysis Patients: A Four-Week Study Using a Widely-Used Communication App in Taiwan. Stud Health Technol Inform. 2024 Aug 22;316:511-512. doi: 10.3233/SHTI240461. PMID: 39176790.

    • 8. Hung KC, Chao CT. Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis. J Am Soc Nephrol. 2024 Aug 1;35(8):1134-1135. doi: 10.1681
    • 9. Hung KC, Chao CT. Statin use, albuminuria, and mortality risk: Re-evaluating C-reactive protein to albumin ratio in hypertensive patients based on NHANES data. Nutr Metab Cardiovasc Dis. 2024 Aug;34(8):2016-2017. doi: 10.1016/j.numecd.2024.03.032. Epub 2024 Apr 14. PMID: 38744583.

    • 10. Hung KC, Chao CT. Instrumental outcome modifiers to be considered among patients with acute heart failure. Int J Cardiol. 2024 Aug 1;408:132145. doi: 10.1016/j.ijcard.2024.132145. Epub 2024 May 8. PMID: 38729308.

    • 11.  Lu KC, Hung KC, Liao MT, Shih LJ, Chao CT. Vascular Calcification Heterogeneity from Bench to Bedside: Implications for Manifestations, Pathogenesis, and Treatment Considerations. Aging Dis. 2024 Apr 20;16(2):683-692. doi: 10.14336/AD.2024.0289. PMID: 38739930; PMCID: PMC11964443.

    • 12.  Hung, K.-C.; Yao, W.-C.; Liu, Y.-L.; Yang, H.-J.; Liao, M.-T.; Chong, K.; Peng, C.-H.; Lu, K.-C. The Potential Influence of Uremic Toxins on the Homeostasis of Bones and Muscles in Chronic Kidney Disease. Biomedicines 2023, 11, 2076. (IF= 4.7, Q1)

    • 13. Jia-Feng Chang; Hsiao-Ling Kuo; Shih-Hao Liu; Chih-Yu Hsieh; Chih-Ping Hsu; Kuo-Chin Hung; Ting-Ming Wang; Chang-Chin Wu; Kuo-Cheng Lu; Wei-Ning Lin; Chi-Feng Hung; Wen-Chin Ko. Translational Medicine in Uremic Vascular Calcification: Scavenging ROS Attenuates p-Cresyl Sulfate-Activated Caspase-1, NLRP3 Inflammasome and Eicosanoid Inflammation in Human Arterial Smooth Muscle Cells. Life 2022, 12, 769. (IF= 3.251, Q2)

    • 14. Ma, L.-C.; Liu, Y.-M.; Lin, Y.-C.; Liao, C.-T.; Hung, K.-C.; Chen, R.; Lu, K.-C.; Ho, K.-F.; Zheng, C.-M. Factors Influencing Self-Management Behaviors among Hemodialysis Patients. J. Pers. Med. 2022, 12, 1816. (IF= 3.4, Q2)

    • 15.  Kuo-Chin Hung; Jia-Feng Chang; Yung-Ho Hsu; Chih-Yu Hsieh; Mai-Szu Wu; Mei-Yi Wu; I-Jen Chiu; Ren-Si Syu; Ting-Ming Wang; Chang-Chin Wu; Lie-Yee Hung; Cai-Mei Zheng; Kuo-Cheng Lu. Therapeutic Effect of Calcimimetics on Osteoclast–Osteoblast Crosslink in Chronic Kidney Disease and Mineral Bone Disease. International Journal of Molecular Sciences 2020, 21, 8712. (IF= 5.6)

    • 16. Kun-Mo Lin; Chien-Lin Lu; Kuo-Chin Hung; Pei-Chen Wu; Chi-Feng Pan; Chih-Jen Wu; Ren-Si Syu; Jin-Shuen Chen; Po-Jen Hsiao; Kuo-Cheng Lu. The Paradoxical Role of Uric Acid in Osteoporosis. Nutrients 2019, 11, 2111. Co-1st -author (IF= 6.706, Q1)
    • 17. 洪國欽,徐仁熙,翁志仁,莊天華,楊麗琼,盧國城:心血管疾病之骨質流失.內科學誌：2015：26：77-87

    • 18. Hung KC, Huang CY, Liu CC, et al.: Serum bone resorption markers after parathyroidectomy for renal hyperparathyroidism: Correlation analyses for the cross-linked n-telopeptide of collagen I and tartrate-resistant acid phosphatase. TheScientificWorldJournal 2012;2012:503945.

    • 19. Zheng, C. M., P. Chu, C. C. Wu, W. Y. Ma, K. C. Hung, Y. H. Hsu, Y. F. Lin, L. K. Diang and K. C. Lu (2012). "Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients." Tohoku J Exp Med 226(1): 19-27. (IF= 2.547, Q2)

    • 20. Liao, M. T., C. C. Sung, K. C. Hung, C. C. Wu, L. Lo and K. C. Lu (2012). "Insulin resistance in patients with chronic kidney disease." J Biomed Biotechnol 2012: 691369. (IF=3.246, Q2)

    • 21.  Ma, W. Y., C. C. Wu, D. Pei, K. C. Hung, T. L. Hsia, C. C. Su, Y. M. Chu and K. C. Lu (2011). "Glycated albumin is independently associated with estimated glomerular filtration rate in nondiabetic patients with chronic kidney disease." Clin Chim Acta 412(7-8): 583-586. (IF= 6.314, Q1)

    • 22.  Lu, K. C., W. Y. Ma, C. C. Chen, K. C. Hung, H. S. Chen, C. C. Wu and T. Y. Chang (2011). "Influence of diabetes on homocysteine-lowering therapy in chronic hemodialysis patients." Clin Chim Acta 412(13-14): 1234-1239. (IF= 6.314, Q1)

    • 23.  Hung, K. C., C. C. Wu, H. S. Chen, W. Y. Ma, C. F. Tseng, L. K. Yang, H. L. Hsieh and K. C. Lu (2011). "Serum IL-6, albumin and co-morbidities are closely correlated with symptoms of depression in patients on maintenance haemodialysis." Nephrol Dial Transplant 26(2): 658-664. (IF= 6.1, Q1)

    • 24.  Hung K-C, Pei D, Kuo H-J, et al.: The comparison of the metabolic syndrome between chinese vegetarians and omnivores. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2008;2:99-104. (IF= 10, Q1)

    • 25. 劉康玲,鍾宜君,洪國欽,楊麗琼:雙磷酸鹽在慢性腎病變合併低骨密度患者的使用. 腎臟與透析：民國 103 年 26 卷 2 期

    • 26. 徐于康,張瀞方,楊麗琼,洪國欽,廖敏策:同型半胱胺酸在末期腎病中所扮演的角色.腎臟與透析：民國102年25卷1期

    • 27. 羅蘭,馬麗卿,洪國欽,劉月敏:糖化白蛋白在糖尿病合併慢性腎臟病之角色. 腎臟與透析：民國101年24卷4期



相關圖片
瀏覽人次：802 人 更新日期：2025-09-12
回上頁 回首頁 TOP